Literature DB >> 6607092

Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey.

J W Langston, L S Forno, C S Rebert, I Irwin.   

Abstract

1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) was administered via the intraperitoneal route to squirrel monkeys. Akinesia, rigidity and hypophonia were seen after repeated doses of 2 mg/kg. Postural tremor was present in one animal. Neuropathologic examination revealed cell loss restricted to the zona compacta of the substantia nigra. MPTP appears effective in producing an animal model for Parkinson's disease in the squirrel monkey, and may be one of the more selective neurotoxins described to date.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6607092     DOI: 10.1016/0006-8993(84)90777-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  120 in total

1.  Striatal responses to partial dopaminergic lesion: evidence for compensatory sprouting.

Authors:  D D Song; S N Haber
Journal:  J Neurosci       Date:  2000-07-01       Impact factor: 6.167

Review 2.  NMDA receptors in the basal ganglia.

Authors:  P Ravenscroft; J Brotchie
Journal:  J Anat       Date:  2000-05       Impact factor: 2.610

Review 3.  Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease.

Authors:  Michel Cyr; Frederic Calon; Marc Morissette; Thérèse Di Paolo
Journal:  J Psychiatry Neurosci       Date:  2002-01       Impact factor: 6.186

4.  Effect of temperature on dopamine transporter function and intracellular accumulation of methamphetamine: implications for methamphetamine-induced dopaminergic neurotoxicity.

Authors:  T Xie; U D McCann; S Kim; J Yuan; G A Ricaurte
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

5.  Increased dopaminergic neuron sensitivity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in transgenic mice expressing mutant A53T alpha-synuclein.

Authors:  Wai Haung Yu; Yasuji Matsuoka; István Sziráki; Audrey Hashim; John Lafrancois; Henry Sershen; Karen E Duff
Journal:  Neurochem Res       Date:  2007-11-13       Impact factor: 3.996

6.  Increased dopamine receptor binding in duodenal mucosa of duodenal ulcer patients.

Authors:  D E Hernandez; C H Walker; J E Valenzuela; G A Mason
Journal:  Dig Dis Sci       Date:  1989-04       Impact factor: 3.199

7.  Neuroprotective effects of alpha-dihydroergocryptine against damages in the substantia nigra caused by severe treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

Authors:  G Bernocchi; G Gerzeli; E Scherini; C Vignola
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

Review 8.  α-Synuclein nonhuman primate models of Parkinson's disease.

Authors:  David J Marmion; Jeffrey H Kordower
Journal:  J Neural Transm (Vienna)       Date:  2017-04-22       Impact factor: 3.575

9.  MPTP Induces Systemic Parkinsonism in Middle-Aged Cynomolgus Monkeys: Clinical Evolution and Outcomes.

Authors:  Feng Yue; Sien Zeng; Rongping Tang; Guoxian Tao; Piu Chan
Journal:  Neurosci Bull       Date:  2016-10-03       Impact factor: 5.203

Review 10.  Neurodegenerative diseases: neurotoxins as sufficient etiologic agents?

Authors:  Christopher A Shaw; Günter U Höglinger
Journal:  Neuromolecular Med       Date:  2007-11-06       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.